HOW TO BUY ACADIA SHARES
Listed at the NASDAQ Exchange (Stock Symbol: ACAD)
How to Open a Trading Account to Invest in How to Buy ACADIA Pharmaceuticals Shares
Opening an investment account with an Online Broker is a process that is completed online and requires:
First, choose the broker that best fits you. Here, we present eToro as the primary choice.
Upload an ID and a proof of address (electricity, water bills, etc.) through the Broker's App or via email.
Whether you open it with eToro or with another broker, make sure to choose the correct base currency of the account. With some brokers, changing it once you open the account can be painful. Trading Accounts are available on US Dollars (USD), Euros (EUR), Pound Sterling (GBP), Swiss Franc (CHF), Australian Dollar (AUD) as the base currency. Practically all of them offer the option in US Dollars or Euros.
Once the Broker has approved the account, it's time to deposit cash. The depositing and withdrawing money methods are usually Credit Cards, Bank Transfers or eWallets (PayPal, PaySafe, Skrill, SafetyPay, Neteller, among others). The available options to deposit funds will depend on each Broker. A vital fact to mention is that all of the Brokers presented above allow you to use a simulator on their platform; that is, they allow testing their Demo account, which is Free. In other words, you can open a Demo account, try the platform, and then decide whether to deposit money or not.
Upon the capital is credited into your credited account, you may now buy the Stock.
Is it easy to invest in ACADIA Pharmaceuticals Shares?
Online Brokers allow investing in Shares straightforwardly through optimised apps that grant easy and fast access to financial markets. Most platforms resemble a social network or any other phone app: They are designed so that the investor can learn and start trading very quickly, without the need for much prior knowledge. To buy shares of ACADIA, you have to:
open a trading account as explained before,
Search for "acadia" on the Broker's Trading platform, and
press the "Buy" button.
And, done, you are officially investing in the co's shares.
About ACADIA Pharmaceuticals
ACADIA Pharmaceuticals was founded in 1993 under the name Receptor Technologies and is a biopharmaceutical company focused on developing and commercialising innovative medicines to address the unmet medical needs of patients suffering from different central nervous system disorders.
The company has developed and commercialised NUPLAZID® (pimavanserin), which received FDA approval in 2016. It is the first and only medicine approved to treat hallucinations and delusions associated with Parkinson’s Disease Psychosis. ACADIA is also engaged in ongoing clinical development efforts in other medical areas with significant unmet needs, such as dementia-related psychosis, schizophrenia, major depressive disorder, Rett syndrome, and more.